A PILOT-STUDY OF THE ADDITION OF ALL-TRANS-RETINOIC ACID (ATRA) TO INTERFERON-ALPHA 2A (IFN) FOR TREATMENT OF CHRONIC MYELOID-LEUKEMIA (CML) AFTER FAILURE OF - (1) IFN IN CHRONIC OR ACCELERATED PHASE, OR (2) RELAPSE POST AUTOLOGOUS BONE-MARROW TRANSPLANT
C. Arthur et al., A PILOT-STUDY OF THE ADDITION OF ALL-TRANS-RETINOIC ACID (ATRA) TO INTERFERON-ALPHA 2A (IFN) FOR TREATMENT OF CHRONIC MYELOID-LEUKEMIA (CML) AFTER FAILURE OF - (1) IFN IN CHRONIC OR ACCELERATED PHASE, OR (2) RELAPSE POST AUTOLOGOUS BONE-MARROW TRANSPLANT, Blood, 88(10), 1996, pp. 3508-3508